P

Inventor

SINGH JUSWINDER

US69 patents
⚠️ This page may combine multiple inventors who share the name “SINGH JUSWINDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CELGENE CAR LLC

17 patents
US9987276B2Jun 5, 2018

Substituted 2,4-diaminopyrimidines as kinase inhibitors

CELGENE CAR LLC23 citations94
US10010548B2Jul 3, 2018

2,4-disubstituted pyrimidines useful as kinase inhibitors

CELGENE CAR LLC15 citations92
US9867824B2Jan 16, 2018

Heterocyclic compounds and uses thereof

CELGENE CAR LLC11 citations92
US10577380B2Mar 3, 2020

MK2 inhibitors and uses thereof

CELGENE CAR LLC10 citations91
US10253040B1Apr 9, 2019

MK2 inhibitors and uses thereof

CELGENE CAR LLC12 citations91
US9790235B2Oct 17, 2017

MK2 inhibitors and uses thereof

CELGENE CAR LLC12 citations91
US10596172B2Mar 24, 2020

2,4-disubstituted pyrimidines useful as kinase inhibitors

CELGENE CAR LLC5 citations84
US10138256B2Nov 27, 2018

MK2 inhibitors and uses thereof

CELGENE CAR LLC11 citations84
US10081606B2Sep 25, 2018

Heteroaryl compounds and uses thereof

CELGENE CAR LLC8 citations84
US9980964B2May 29, 2018

ERK inhibitors and uses thereof

CELGENE CAR LLC11 citations84
US9796700B2Oct 24, 2017

ERK inhibitors and uses thereof

CELGENE CAR LLC7 citations84
US9765038B2Sep 19, 2017

Heteroaryl compounds and uses thereof

CELGENE CAR LLC11 citations84
US10434101B2Oct 8, 2019

Heterocyclic compounds and uses thereof

CELGENE CAR LLC4 citations83
US9695132B2Jul 4, 2017

Heteroaryl compounds and uses thereof

CELGENE CAR LLC5 citations83
US9663524B2May 30, 2017

Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors

CELGENE CAR LLC15 citations82
US11351168B1Jun 7, 2022

2,4-disubstituted pyrimidines useful as kinase inhibitors

CELGENE CAR LLC2 citations73
US10828300B2Nov 10, 2020

Substituted 2,4-diaminopyrimidines as kinase inhibitors

CELGENE CAR LLC3 citations73

CELGENE AVILOMICS RES INC

15 patents
US8609679B2Dec 17, 2013

2,4-diaminopyrimidines useful as kinase inhibitors

CELGENE AVILOMICS RES INC84 citations99
US9212181B2Dec 15, 2015

Substituted 2,4-diaminopyrimidines as kinase inhibitors

CELGENE AVILOMICS RES INC34 citations98
US9561228B2Feb 7, 2017

ERK inhibitors and uses thereof

CELGENE AVILOMICS RES INC37 citations97
US8710222B2Apr 29, 2014

2,4-disubstituted pyrimidines useful as kinase inhibitors

CELGENE AVILOMICS RES INC52 citations97
US9409921B2Aug 9, 2016

2,4-disubstituted pyrimidines as kinase inhibitors

CELGENE AVILOMICS RES INC25 citations94
US9296737B2Mar 29, 2016

Substituted 2,4-diaminopyrimidines as kinase inhibitors

CELGENE AVILOMICS RES INC27 citations94
US9375431B2Jun 28, 2016

2,4-disubstituted pyrimidine compounds useful as kinase inhibtors

CELGENE AVILOMICS RES INC21 citations92
US9321786B2Apr 26, 2016

Heteroaryl compounds and uses thereof

CELGENE AVILOMICS RES INC15 citations92
US9145387B2Sep 29, 2015

ERK inhibitors and uses thereof

CELGENE AVILOMICS RES INC21 citations92
US9458175B2Oct 4, 2016

MK2 inhibitors and uses thereof

CELGENE AVILOMICS RES INC16 citations91
US9504686B2Nov 29, 2016

ERK inhibitors and uses thereof

CELGENE AVILOMICS RES INC10 citations84
US9040541B2May 26, 2015

4,6-disubstituted pyrimidines useful as kinase inhibitors

CELGENE AVILOMICS RES INC5 citations84
US8980935B2Mar 17, 2015

HCV protease inhibitors and uses thereof

CELGENE AVILOMICS RES INC7 citations84
US8748606B2Jun 10, 2014

4,6-diaminopyrimidines useful as kinase inhibitors

CELGENE AVILOMICS RES INC8 citations84
US9393246B2Jul 19, 2016

4,6-disubstituted pyrimidines as kinase inhibitors

CELGENE AVILOMICS RES INC3 citations73

SINGH JUSWINDER

6 patents

NIU DEQIANG

5 patents

LEE KWANGHO

2 patents

BIOGEN INC

2 patents

AVILA THERAPEUTICS INC

2 patents

PETTER RUSSELL C

1 patent

Showing the top 50 of 69 patents by PatentIndex Score.